United Biomedical, a Taiwan biopharmaceutical firm developing COVID-19 vaccines, on Thursday said it had initially planned on following international norm and entering phase 3 clinical trials before seeking government approval for its COVID-19 vaccine.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Sports
Taiwan bags silver medals in men's, women's team soft tennis
09/20/2026 07:57 PM - Politics
Labor minister heads to China for APEC meeting
09/20/2026 07:56 PM - Society
Favorable weather to allow Mid-Autumn Festival moon gazing: CWA
09/20/2026 07:40 PM - Culture
Lai outlines 4 priorities for Taiwan's cultural future at congress
09/20/2026 07:20 PM - Society
Over 21,000 swimmers participate in annual Sun Moon Lake swim fest
09/20/2026 04:56 PM